<ARTICLE> 5 <LEGEND> This schedule contains summary information extracted from the Statements of Operations and Balance Sheets of InVitro International and is qualified in its entirety by reference to such financial statements. </LEGEND> <CIK> 0000872610 <NAME> INVITRO INTERNATIONAL <MULTIPLIER> 1000 <FISCAL-YEAR-END> Sep-30-1997 <PERIOD-START> Oct-01-1996 <PERIOD-END> Mar-31-1997 <PERIOD-TYPE> 6-MOS <CASH> 383 <SECURITIES> 0 <RECEIVABLES> 167 <ALLOWANCES> 10 <INVENTORY> 503 <CURRENT-ASSETS> 1,088 <PP&E> 1,043 <DEPRECIATION> 861 <TOTAL-ASSETS> 1,414 <CURRENT-LIABILITIES> 259 <BONDS> 0 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 25,036 <OTHER-SE> (23,881) <TOTAL-LIABILITY-AND-EQUITY> 1,414 <SALES> 423 <TOTAL-REVENUES> 423 <CGS> 289 <TOTAL-COSTS> 1,346 <OTHER-EXPENSES> (22) <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 0 <INCOME-PRETAX> (901) <INCOME-TAX> 0 <INCOME-CONTINUING> (901) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (901) <EPS-PRIMARY> (.06) <EPS-DILUTED> (.06)